Pulmonx Stock (NASDAQ: LUNG) stock price, news, charts, stock research, profile.
Open | $7.450 |
Close | $7.430 |
Volume / Avg. | 358.066K / 555.982K |
Day Range | 7.310 - 7.580 |
52 Wk Range | 7.340 - 14.835 |
Market Cap | $288.372M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 4.14% |
Days to Cover | 1.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pulmonx (NASDAQ: LUNG) through any online brokerage.
Other companies in Pulmonx’s space includes: NeuroPace (NASDAQ:NPCE), Axogen (NASDAQ:AXGN), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR) and AngioDynamics (NASDAQ:ANGO).
The latest price target for Pulmonx (NASDAQ: LUNG) was reported by Piper Sandler on Wednesday, April 3, 2024. The analyst firm set a price target for 17.00 expecting LUNG to rise to within 12 months (a possible 128.80% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Pulmonx (NASDAQ: LUNG) is $7.43 last updated April 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Pulmonx.
Pulmonx’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Pulmonx.
Pulmonx is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.